Join Tom and Mike as they share an important update on Tom's prostate cancer journey. In this video, they discuss Tom's ...

Fixed infusion rate (FIR) gemcitabine (G) based treatment for advanced renal cell carcinoma (ARCC): Efficacy and toxicity data from a phase II study No significant financial relationships to disclose.

SAN ANTONIO -- Men with intermediate- and high-risk prostate cancer treated with external-beam pelvic radiotherapy (EBRT) had better quality of life (QOL) outcomes when the combined prostate ...

If it's cutting edge treatment, chances are good it's offered at Cancer Treatment Centers of America. Staff at the center recently performed their 700th prostate HDR brachytherapy procedure. Though ...

(HealthDay News) — For men with prostate cancer there is no difference in acute genitourinary or sexual dysfunction between 6- and 2-fraction high-dose-rate (HDR) brachytherapy monotherapy, according ...

High-dose-rate (HDR) brachytherapy may be a suitable option for men with localized prostate cancer who previously have undergone transurethral resection of the prostate (TURP), according to ...

Biobot Surgical, a robotic-assisted percutaneous surgical systems company, announced an MOU with BEBIG Medical, a global provider of radiotherapy products and a brachytherapy leader based in Europe to ...

GE HealthCare Technologies’ Inc. GEHC MIM Software recently introduced the MIM Symphony HDR Prostate to support high dose-rate (HDR) brachytherapy. This novel solution provides direct tumor ...

Phase II study of thalidomide, Interleukin-2 (IL-2), and granulocyte macrophage-colony stimulating factor (GM-CSF) in patients (pts) with metastatic renal cell carcinoma (MRCC) No significant ...